AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 30395812
Drug: RPC4046 180
RxNorm normalized name: IMMUNOGLOBULIN G1(240-ALANINE, 241-ALANINE), ANTI-(HUMAN INTERLEUKIN 13) (HUMAN-MUS MUSCULUS MONOCLONAL RPC4046 .GAMMA.-1), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL RPC4046 .KAPPA.-1, DIMER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RPC4046 180 mg
Trial: 30395812
Drug: RPC4046 360
RxNorm normalized name: IMMUNOGLOBULIN G1(240-ALANINE, 241-ALANINE), ANTI-(HUMAN INTERLEUKIN 13) (HUMAN-MUS MUSCULUS MONOCLONAL RPC4046 .GAMMA.-1), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL RPC4046 .KAPPA.-1, DIMER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RPC4046 360 mg
Trial: 18363424
Drug: Multi-family psychoeducational
RxNorm normalized name: Parasedge Multi
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multi-family psychoeducational group + pharmacotherapy
Trial: 15555694
Drug: Pharmacotherapy alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmacotherapy alone
Trial: 9177961
Drug: Five-day treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Five-day treatment with cefprozil
Trial: 9177961
Drug: Ten-day treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ten-day treatment with cefprozil (in patients with three or more previous episodes)
Trial: 3100466
Drug: Stanozolol (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stanozolol (10 mg/day)
Trial: 27026642
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg of prednisone orally followed by 2 doses of intravenous hydrocortisone, each 8 hours apart
Trial: 25049134
Drug: Exendin‐[9‐39] (Ex‐9)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exendin‐[9‐39] (Ex‐9) infusion (600‐750 pmol/kg/min)
Trial: 20413036
Drug: Placebo (saline)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (saline) infusion
Trial: 22554716
Drug: Cystagon (immediate-release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cystagon (immediate-release cysteamine bitartrate) taken every 6 hours
Trial: 22554716
Drug: RP103 (delayed-release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RP103 (delayed-release cysteamine bitartrate)
Trial: 14970004
Drug: Growth hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth hormone (GH) infusion
Trial: 10473874
Drug: GPIIb/IIIa inhibitors
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GPIIb/IIIa inhibitors
Trial: 2273204
Drug: Estrogen/progesterone therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estrogen/progesterone therapy
Trial: 7375871
Drug: Single oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single oral dose of 50 mg indomethacin
Trial: 7375871
Drug: Indomethacin 25
RxNorm normalized name: indomethacin 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin 25 mg q.i.d. for 8 days
Trial: 30004624
Drug: Intraoperative remifentanil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraoperative remifentanil infusion (0.2 μg/kg/min) discontinued upon surgery completion
Trial: 12199627
Drug: IFL combination
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IFL combination (fluorouracil [5‐FU], leucovorin, and irinotecan [CPT‐11, Camptosar])
Trial: 9569999
Drug: Non-steroidal anti-inflammatory
RxNorm normalized name: Non-steroidal anti-inflammatory agent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-steroidal anti-inflammatory drugs (NSAIDs) including aspirin, diclofenac, naproxen, indomethacin, and ibuprofen
Trial: 3195729
Drug: 3 mg
RxNorm normalized name: boron 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 mg EM with 0.125% bupivacaine
Trial: 23227695
Drug: Shu-needle therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Shu-needle therapy combined with ozone injection of low concentration
Trial: 23227695
Drug: Conventional acupotomy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional acupotomy therapy combined with ozone injection of low concentration
Trial: 19036146
Drug: Transarterial chemoembolization
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transarterial chemoembolization plus sorafenib 400 mg bid
Trial: 16096175
Drug: Transdermal HRT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal HRT (Estalis)
Trial: 16096175
Drug: Oral HRT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral HRT (Kliogest)
Trial: 25222574
Drug: Intra-articular magnesium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intra-articular magnesium sulphate (100 mg/mL, 10 mL)
Trial: 19800815
Drug: Normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline (10 mL)
Trial: 15522005
Drug: Rifaximin treatment
RxNorm normalized name: Rifaximin
DrugBank: Rifaximin (DB01220)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Rifaximin treatment for 3 days
Trial: 15522005
Drug: Rifaximin treatment
RxNorm normalized name: Rifaximin
DrugBank: Rifaximin (DB01220)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Rifaximin treatment
Trial: 10328567
Drug: Intranasal diazepam
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal diazepam (2 mg)
Trial: 10328567
Drug: Intravenous diazepam
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous diazepam (2 mg)
Trial: 22427020
Drug: Caffeine (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine (2 mg/kg)
Trial: 11514302
Drug: Caffeine (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine (4 mg/kg)
Trial: 637293
Drug: Two vial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two vial formulation of etomidate (30 mg etomidate sulphate in 20 ml phosphate buffered solution)
Trial: 637293
Drug: New formulation
RxNorm normalized name: TRIPROLIDINE HYDROCHLORIDE 1.25 mg in 1 mL ORAL SYRUP [HISTEX PD Drops New Formulation]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New formulation of etomidate (5ml ampoules containing 2% etomidate base in polyethylene glycol 1000)
Trial: 637293
Drug: Two vial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two vial formulation of etomidate
Trial: 31596411
Drug: Infant stimulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infant stimulation therapy (auditory, tactile, visual and vestibular)
Trial: 17272285
Drug: Community pharmacy-led
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Community pharmacy-led medicines management intervention
Trial: 14757388
Drug: L-alanyl-L-glutamine-supplemented TPN
RxNorm normalized name: L-Alanyl-L-glutamine
DrugBank: Alanyl glutamine (DB11876)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-alanyl-L-glutamine-supplemented TPN (0.40 g/kg/d)
Trial: 9768932
Drug: Low-dose tranexamic
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose tranexamic acid (group TA; n = 14)
Trial: 804952
Drug: Tolamolol 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tolamolol 200 mg thrice daily
Trial: 804952
Drug: Tolamolol (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tolamolol (both doses)
Trial: 28202067
Drug: Acupuncture in
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture in addition to standard treatment (N=61 for each study group)
Trial: 28202067
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment alone (N=61 for each control group)
Trial: 28202067
Drug: Acupuncture in
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture in addition to standard treatment
Trial: 7509509
Drug: 750 anti-factor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 750 anti-factor Xa units of Orgaran given subcutaneously twice-daily
Trial: 26181299
Drug: Overall preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Overall preparation
Trial: 16414445
Drug: Fermentable carbohydrate
RxNorm normalized name: pyrrolidone carboxylate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fermentable carbohydrate (FC) supplementation (40 g/d)
Trial: 9299800
Drug: Fluoxetine alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine alone
Trial: 29921144
Drug: PCIT-ED (Parent-Child
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PCIT-ED (Parent-Child Interaction Therapy with Emotion Development module)
Trial: 21988525
Drug: Behavioural Medicine
RxNorm normalized name: Medicaine Sting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Behavioural Medicine Rehabilitation (BM)
Trial: 11240079
Drug: Treatment-as-usual (CG)
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment-as-usual (CG)
Trial: 20195472
Drug: Intermittent preventive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermittent preventive treatment (IPTp) with sulphadoxine‐pyrimethamine (SP)
Trial: 7569737
Drug: Iodixanol 320
RxNorm normalized name: IODIXANOL 320mgI/ml INJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iodixanol 320 mgI ml‐1
Trial: 28382892
Drug: Lipid-based nutrient
RxNorm normalized name: guggul lipids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lipid-based nutrient supplement (LNS), 20 g sachet given from 6 to 18 months
Trial: 26529126
Drug: Broad spectrum
RxNorm normalized name: Broad spectrum penicillin
DrugBank: Octinoxate (DB09496)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Broad spectrum antibiotic treatment
Trial: 19388508
Drug: Preload/Coload (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preload/Coload (10 mL/kg before and 10 mL/kg after SAB)
Trial: 19388508
Drug: Preload (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preload (20 mL/kg crystalloid infusion before SAB)
Trial: 17416261
Drug: Darunavir-ritonavir 600/100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Darunavir-ritonavir 600/100 mg twice daily
Trial: 17617272
Drug: Lopinavir-ritonavir 400/100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lopinavir-ritonavir 400/100 mg twice daily
Trial: 10334150
Drug: Ipratropium bromide
RxNorm normalized name: Ipratropium Bromide
DrugBank: Ipratropium (DB00332)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ipratropium bromide inhalation solution 0.02% (qid)
Trial: 7486611
Drug: Dextrorphan HCl
RxNorm normalized name: Chlorpromazine Hydrochloride
DrugBank: Dextrorphan (DB14682)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dextrorphan HCl (Ro 01‐6794/706) administered as a loading dose of 200 mg/hr or greater
Trial: 7486611
Drug: Dextrorphan HCl
RxNorm normalized name: Chlorpromazine Hydrochloride
DrugBank: Dextrorphan (DB14682)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dextrorphan HCl (Ro 01‐6794/706) administered as a loading dose below 200 mg/hr
Trial: 28670117
Drug: Dietary beetroot
RxNorm normalized name: sodium phosphate, monobasic
DrugBank: Sodium phosphate, monobasic (DB09449)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dietary beetroot juice (BR) - 2×70 mL twice daily, each containing 300 mg nitrate
Trial: 28670117
Drug: Placebo (PL)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (PL) - 2×70 mL twice daily, nitrate-negligible
Trial: 30232958
Drug: Multiple doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiple doses of salbutamol/ambroxol fixed-dose combination granules
Trial: 9085961
Drug: Intravenous (I.V.)
RxNorm normalized name: immunoglobulins, intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous (I.V.) clonidine 4 microg/kg
Trial: 27592594
Drug: Daily reminder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily reminder
Trial: 27592594
Drug: Daily lottery-based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily lottery-based incentive
Trial: 25623564
Drug: Tiotropium bromide
RxNorm normalized name: Tiotropium Bromide
DrugBank: Tiotropium (DB01409)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tiotropium bromide (5 µg) via Respimat, once daily for 48 weeks
Trial: 16150917
Drug: High-dose PYY(3‐36)
RxNorm normalized name: PYY(3-36)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose PYY(3‐36) (100 nmol/kg)
Trial: 16150917
Drug: High-dose GLP‐1(7‐36)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose GLP‐1(7‐36) (100 nmol/kg)
Trial: 16150917
Drug: Low-dose PYY(3‐36)
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose PYY(3‐36) (1 nmol/kg) + GLP‐1(7‐36) (10 nmol/kg)
Trial: 1814742
Drug: Potassium chloride
RxNorm normalized name: Potassium Chloride
DrugBank: Potassium chloride (DB00761)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Potassium chloride solution (PS)
Trial: 1814742
Drug: Potassium chloride
RxNorm normalized name: Potassium Chloride
DrugBank: Potassium chloride (DB00761)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Potassium chloride wax-matrix tablets (WMT)
Trial: 6235834
Drug: Spironolactone (50-200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spironolactone (50-200 mg daily)
Trial: 11293926
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no supplements)
Trial: 22932716
Drug: Vorapaxar (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vorapaxar (2.5 mg daily)
Trial: 18030518
Drug: Pre-neoadjuvant chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pre-neoadjuvant chemotherapy (NACT) with silver wire markers for tumor margins
Trial: 11988148
Drug: Specific immunotherapy
RxNorm normalized name: Pacific halibut
DrugBank: Pacific halibut (DB10616)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Specific immunotherapy with latex (active treatment)
Trial: 10367539
Drug: Gemcitabine 1000
RxNorm normalized name: gemcitabine 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemcitabine 1000 mg/m2/week intravenously diluted in 250 cc of normal saline as 20 minutes infusion for 3 consecutive weeks followed by a 1 week rest period
Trial: 10367539
Drug: Gemcitabine 1000
RxNorm normalized name: gemcitabine 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemcitabine 1000 mg/m2/week
Trial: 1856249
Drug: Ferrous sulphate
RxNorm normalized name: Ferrous sulphate
DrugBank: Ferrous fumarate (DB14491)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ferrous sulphate (equivalent dose)
Trial: 28864708
Drug: Carnosine (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carnosine (2 g daily in two divided doses)
Trial: 19784813
Drug: Therapeutic angiogenesis
RxNorm normalized name: Moisturel Therapeutic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Therapeutic angiogenesis (gene and cell therapy)
Trial: 11813739
Drug: Verbal advice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verbal advice plus written prescription (green prescription)
Trial: 10676820
Drug: lesopitron 4‐80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: lesopitron 4‐80 mg/d
Trial: 10676820
Drug: lorazepam 2‐4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: lorazepam 2‐4 mg/d
Trial: 9094885
Drug: Modifications reducing
RxNorm normalized name: Iron, reduced
DrugBank: Iron (DB01592)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Modifications reducing body mass index by 5 kg/m2, quitting a 10 cigarette/d smoking habit, and reducing dietary cholesterol intake by 100 mg/d
Trial: 22897460
Drug: Aliskiren/amlodipine 150/5mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aliskiren/amlodipine 150/5mg for 1 week, then up-titration to 300/10 mg for 7 weeks
Trial: 18574751
Drug: 20 mug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mug inhaled procaterol
Trial: 11839447
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg gum
Trial: 11839447
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg capsule
Trial: 8750368
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg capsule
Trial: 11839447
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg capsule
Trial: 11839447
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg gum
Trial: 11839447
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg gum
Trial: 11839447
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg gum (normalized to total drug released)
Trial: 11839447
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg gum (normalized to total drug released)
Trial: 11839447
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg gum (normalized to total drug released)
Trial: 10506315
Drug: Atracurium (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atracurium (all doses)
Trial: 7672088
Drug: Immediate treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate treatment with chlorambucil (CLB)
Trial: 7672088
Drug: Deferred therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Deferred therapy until progression
Trial: 2178298
Drug: AVP antagonist
RxNorm normalized name: Interleukin-1 receptor antagonist anakinra
DrugBank: Anakinra (DB00026)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: AVP antagonist [d(CH2)5 Tyr(Me)AVP] 5 micrograms/kg
Trial: 31810437
Drug: Cannabidiol (CBD)
RxNorm normalized name: cannabidiol (CBD)
DrugBank: Cannabidiol (DB09061)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Cannabidiol (CBD) - 100 mg/mL formulation, dose range 50 mg to 600 mg per day, titrated over 2 weeks followed by a 2-week assessment period.
Trial: 28449630
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (not explicitly mentioned, assumed to be rocuronium at 0.45 mg/kg)
Trial: 7846463
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg melatonin administered at 1200 hours
Trial: 27866000
Drug: Photodynamic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Photodynamic therapy without optical fiber
Trial: 19815042
Drug: Multi-micronutrient supplements
RxNorm normalized name: Parasedge Multi
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multi-micronutrient supplements
Trial: 22120092
Drug: Tolvaptan 15
RxNorm normalized name: tolvaptan 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tolvaptan 15 mg/day for 7 days
Trial: 15464333
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg vardenafil
Trial: 21934637
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg vardenafil
Trial: 28052576
Drug: 250 mL/day ONS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 mL/day ONS and dietary advice
Trial: 26168834
Drug: Goal-directed fluid
RxNorm normalized name: direct blue 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Goal-directed fluid therapy (GDFT) with LiDCO rapid system
Trial: 26168834
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (routine fluid therapy)
Trial: 9161390
Drug: Nonprotocol use
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonprotocol use of antibiotics
Trial: 3304371
Drug: Isosorbide dinitrate
RxNorm normalized name: Isosorbide Dinitrate
DrugBank: Isosorbide dinitrate (DB00883)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isosorbide dinitrate (1.5‐15 mg/hr)
Trial: 27555168
Drug: Rocuronium (0.9
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rocuronium (0.9 mg/kg) administered in the MR group (35 patients)
Trial: 25496296
Drug: Housing First
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Housing First treatment model
Trial: 8160607
Drug: Intravenous thrombolysis
RxNorm normalized name: thrombocytin
DrugBank: Serotonin (DB08839)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous thrombolysis with chest pain present at onset (n = 3000)
Trial: 8160607
Drug: Intravenous thrombolysis
RxNorm normalized name: thrombocytin
DrugBank: Serotonin (DB08839)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous thrombolysis without chest pain present at onset (n = 337)
Trial: 3371394
Drug: Conventional metoprolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional metoprolol tablets, 50 mg twice daily
Trial: 30477869
Drug: Verum Acupuncture
RxNorm normalized name: Cinnamomum verum whole extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verum Acupuncture Group 1 (VA1, 3 times weekly for 4 weeks)
Trial: 30477869
Drug: Verum Acupuncture
RxNorm normalized name: Cinnamomum verum whole extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verum Acupuncture Group 2 (VA2, twice weekly for 4 weeks)
Trial: 30477869
Drug: Sham Acupuncture
RxNorm normalized name: BLACK BEAN ANTI HAIR LOSS SHAM POO SET KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham Acupuncture Group (SA, twice weekly for 4 weeks)
Trial: 24135427
Drug: Oral propranolol,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral propranolol, 2 mg/kg/day
Trial: 24135427
Drug: Topical propranolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical propranolol 1% ointment twice daily
Trial: 24135427
Drug: Intralesional propranolol,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intralesional propranolol, 1 mg in 1 ml injection once weekly
Trial: 11518628
Drug: Topiramate medium
RxNorm normalized name: Topiramate
DrugBank: Topiramate (DB00273)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Topiramate medium dosage (200 mg daily)
Trial: 7950197
Drug: Mixture ATP
RxNorm normalized name: brown mixture
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mixture ATP (General therapy)
Trial: 28545400
Drug: Behavioural medicine
RxNorm normalized name: Medicaine Sting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Behavioural medicine intervention in physiotherapy (goal-setting, self-monitoring, feedback) for 4 months